Major Oslo Cancer Cluster delegation to Nordic Life Science Days/ECCP2014

The largest Nordic Life Science conference “Nordic Life Science Days” (NLSDays) will take place in Stockholm September 7-9. At present 652 delegates from 456 companies are registered – offering 339 licencing opportunities.

A large delegation from Oslo Cancer Cluster will join this years NLSDays that also features the European Cancer Cluster Partnering, which Oslo Cancer Cluster hosts together with French Cancer Bio-Santé.

17 members present
As of now, 17 Oslo Cancer Cluster member companies will be present at NLSDays/ECCP: APIM Therapeutics, Inven2, Nextera, Ultimovacs, Lifandis, Vaccibody, Norwegian Cancer Society, LINK Medical Research, Lytix Biopharma, Targovax, NTNU Technology Transfer, Oncoimmunity, Bergen Technology Transfer, Birk Venture, Oslo University Hospital, University of Oslo and PCI Biotech.

ECCP Oncology Track
The ECCP Oncology Track features a strong oncology program focusing on three major topics; early stage oncology possibilities, Immuno-Oncology and the coupling of biomarkers, bio banks and big data in cancer treatment. Major international speakers will join and the program covers the whole value chain from research to market.

Norwegian stand promoting Norwegian Healthcare Industry
Kindly sponsored by Innovation Norway, Oslo Cancer Cluster and Nansen Neuroscience Network organizes a joint conference booth promoting cluster members and the Norwegian Life Science sector. Please come and visit us to hear more about the strengths of Norwegian Healthcare Industry. The joint Norwegian Stand will be served by the Management Teams of both clusters.

More information www.nlsdays.com

 

Nordic Life Science Days and ECCP2014 merge

Stocholm

Oslo Cancer Cluster and French partner Cancer-Bio-Santé are joining forces with SwedenBio to offer the global Life Science industry the largest partnering conference in the Nordics – Nordic Life Science Days featuring the 6th European Cancer Cluster Partnering.

Already now oncology biotechs, early stage companies and academics may submit an application for presenting at NLSDays-ECCP 2014 – see more info here.

The 6th European Cancer Cluster Partnering (ECCP) will be integrated in the Nordic Life Science Days in Stockholm September 7. – 9, 2014 as a special Oncology track. Cancer clusters from different European countries have already indicated their interest to team-up for the combined ECCP Oncology stream and the joint event.

“This collaboration is an excellent opportunity to further strengthen the European Cancer Cluster Partnering Platform we have built together with our partner Cancer-Bio-Santé since 2009. The joint event offers enhanced partnering opportunities with more than 800 international delegates and allows us to bring ECCP to Scandinavia once again”, says Oslo Cancer Cluster’s international advisor Jutta Heix.

Olivier Duchamp, Managing Director for Nordic Life Science Days is extremely pleased with the success of last years’ event and says: “This year, our aim is to enhance the Nordic region furthermore and be very focused on recent trends and success stories. We obviously contribute an add-on value to the international partnering arena.”

The 2014 website is launched, and delegates are welcome to register at www.nlsdays.com. Download the press release from the web launch here (pdf).

About Nordic Life Science Days (NLSDays)
Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech, but also from finances, research, policy and regulatory authorities. It is the largest Nordic partnering conference for the global Life Science industry, bringing together the best talents in Life Science, offering the excellent networking and partnering opportunities, providing inputs and content on the most recent trends.

About European Cancer Cluster Partnering (ECCP)
Since 2009, ECCP – the European Cancer Cluster Partnering has been established as an annual partnering arena for the international oncology community. ECCP offers a vital networking arena and is the direct result of the close collaboration between two of Europe’s strongest cancer clusters, the French Cancer-Bio Santé Cluster and the Norwegian Oslo Cancer Cluster. The key goal of ECCP is building partnerships to accelerate innovation in cancer treatment.